Synapse - Weinberg Fellows

Results (2836)

Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study

Journal Article

Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
JTO Clinical and Research Reports (2025)

Fulltext@MSK | Save

Brief report: Clinical characteristics and outcomes of patients with thoracic SMARCA4-deficient undifferentiated tumors

Journal Article

Cooper, A. J.; Arfe, A.; Ricciuti, B.; Gagné, A.; Sholl, L. M.; Di Federico, A.; Awad, M. M.; Aldea, M.; Ghigna, M. R.; Grecea, M.; more...
JTO Clinical and Research Reports (2025)

Fulltext@MSK | Save

Prospective study of patient, nursing, and oncology provider perspectives on telemedicine visits for renal cell carcinoma clinical trials

Journal Article

Doshi, S. D.; Knezevic, A.; Gonzalez, C.; Fischer, P.; Goodman, R.; Gornell, S.; Patel, S.; Puzio, C.; Ritea, A.; Lee, C. H.; more...
Clinical Genitourinary Cancer (2025)

Fulltext@MSK | Save

Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia

Journal Article

Chin, K. K.; Valtis, Y.; Derkach, A.; Yisraeli Salman, M.; Boussi, L.; Ciervo, J.; Geyer, M. B.; Park, J. H.; Tallman, M. S.; Glass, J. L.; more...
Blood Neoplasia (2024)

Fulltext@MSK | Save

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Journal Article

Ghione, P.; Bantilan, K. S.; Joffe, E.; Palomba, M. L.; Noy, A.; Caron, P.; Hamlin, P.; Kumar, A.; Matasar, M.; Owens, C.; more...
Blood Neoplasia (2024)

Fulltext@MSK | Save

A multi-site break through cancer trial: Phase II study investigating dual inhibition of BCL2 and menin in AML MRD using the combination of venetoclax and revumenib (trial in progress)

Meeting Abstract

Issa, G. C.; Ambinder, A. J.; Xiao, W.; Manalis, S.; Shalek, A. K.; Gondek, L. P.; Kentsis, A.; Short, N. J.; Daver, N.; Ning, J.; more...
Blood (2024)

Fulltext@MSK | Save

Results from the Great Britain AML real world evidence (ARC) initiative - A centre-based chart review study to assess treatment outcomes of venetoclax for the treatment of acute myeloid leukemia

Meeting Abstract

O'Nions, J.; Errico, G.; Floro, L.; Murthy, V.; Sweeney, C.; Kaur, H.; Mohite, U.; Ayto, R.; Alvares, C.; Goldberg, A. D.; more...
Blood (2024)

Fulltext@MSK | Save

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma

Meeting Abstract

Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
Blood (2024)

Fulltext@MSK | Save

Rituximab plus /- ibrutinib as first line therapy for marginal zone lymphoma

Meeting Abstract

Noy, A.; Thet, W. S.; Vemuri, S.; Seshan, V.; Batlevi, C. L.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Habermann, T. M.; Hamlin, P. A.; more...
Blood (2024)

Fulltext@MSK | Save

Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation

Meeting Abstract

Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
Blood (2024)

Fulltext@MSK | Save